NTBLQ.US Notable Labs, Ltd.

Healthcare Biotechnology USA Stocks
0.0000 USD
Close of Nov 17, 2026
Market cap
USD 96.00
P/E
-
P/B
-
ROE
-250.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2024.

Is NTBLQ.US undervalued?

Graham number

The Graham number of Notable Labs, Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Notable Labs, Ltd. fundamental analysis

No fundamental analysis for Notable Labs, Ltd. yet.

Notable Labs, Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Notable Labs, Ltd.

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive medicines for patients with cancer. The company, through its proprietary Predictive Medicines Platform (PMP), bio-simulates a patient's cancer treatment and predicts whether patient will clinically respond to their actual treatment. Its PMP is designed to identify and select patients expected to be clinically responsive prior to the initiation of their treatment and enable fast-track ther…

Full company profile